CAMBRIDGE TRUST CO - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 5 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CAMBRIDGE TRUST CO ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$63,240
-53.3%
2,000
-39.8%
0.00%
-50.0%
Q2 2023$135,471
+9.4%
3,3220.0%0.01%0.0%
Q1 2023$123,811
+106633.6%
3,3220.0%0.01%
+20.0%
Q4 2022$116
-99.9%
3,3220.0%0.01%
-44.4%
Q3 2022$186,000
+8.1%
3,3220.0%0.01%
+12.5%
Q2 2022$172,000
-28.6%
3,3220.0%0.01%0.0%
Q1 2022$241,000
-38.5%
3,3220.0%0.01%
-38.5%
Q4 2021$392,000
+83.2%
3,322
+151.3%
0.01%
+62.5%
Q2 2021$214,0001,3220.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders